e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 Journal of Medical Internet Research
- 1 JMIR Formative Research
- 1 JMIR Neurotechnology
- 1 JMIR Research Protocols
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Finally, these populations offer a contrast between aging with a degenerative condition (MS) and nonprogressive conditions (TBI and SCI).
This study will pursue 3 objectives aimed at providing insights into the experiences and needs regarding the social participation of individuals aging with neurological disabilities.
JMIR Res Protoc 2025;14:e66963
Download Citation: END BibTex RIS
People living with multiple sclerosis (MS) are tasked with adjusting to substantial prognostic uncertainty, in the absence of clarity regarding the etiology of symptoms and without access to a cure. Critical events, such as receiving an MS diagnosis and ongoing illness stressors, can disrupt emotional equilibrium [1]. It is well established that depressive, anxiety, and stress symptoms are highly prevalent in the population with MS [2].
J Med Internet Res 2024;26:e60240
Download Citation: END BibTex RIS
Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system (CNS), characterized by neuroinflammation, demyelination, neuronal loss, and gliosis, primarily mediated by T and B lymphocytes [1]. Patients with MS experience significant sleep disturbances, far exceeding those of the general population [2].
JMIR Form Res 2024;8:e55408
Download Citation: END BibTex RIS
The final use cases for MS are as follows:
Detecting silent progression: making use of more granular measurements to detect otherwise invisible markers of progression, enabling patients to evidence changes they experience.
Detecting depression: identifying markers of depression in the first year after MS diagnosis.
Data donation: automatic collection and storage of patient data in biobanks or mega-databases.
JMIR Neurotech 2023;2:e41439
Download Citation: END BibTex RIS
Multiple sclerosis (MS) is a chronic neurological disease that affects over 2 million people globally [1]. The disease course of MS is highly variable and can be associated with a progressive decline in physical and cognitive function. The current treatment for MS involves the use of disease-modifying treatments and symptom management; however, the delivery of health care for MS is becoming increasingly supported by digital health interventions.
J Med Internet Res 2022;24(2):e27735
Download Citation: END BibTex RIS